1.Schrauwers, C, Dekker, G. Maternal and perinatal outcome in obese pregnant patients. J Matern Fetal Neonatal Med. 2009; 22, 218–226.
2.Ogden, CL, Carroll, MD, Curtin, LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006; 295, 1549–1555.
3.Kristensen, J, Vestergaard, M, Wisborg, K, Kesmodel, U, Secher, NJ. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG. 2005; 112, 403–408.
4.Ehrenberg, HM, Mercer, BM, Catalano, PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004; 191, 964–968.
5.Jaipaul, JV, Newburn-Cook, CV, O'Brien, B, Demianczuk, N. Modifiable risk factors for term large for gestational age births. Health Care Women Int. 2009; 30, 802–823.
6.Perlow, JH, Morgan, MA, Montgomery, D, Towers, CV, Porto, M. Perinatal outcome in pregnancy complicated by massive obesity. Am J Obstet Gynecol. 1992; 167, 958–962.
7.Mathew, M, Machado, L, Al-Ghabshi, R, Al-Haddabi, R. Fetal macrosomia. Risk factor and outcome. Saudi Med J. 2005; 26, 96–100.
8.Gardosi, J, Francis, A. Adverse pregnancy outcome and association with small for gestational age birthweight by customized and population-based percentiles. Am J Obstet Gynecol. 2009; 201, 28e1–28e8.
9.Akyol, A, Langley-Evans, SC, McMullen, S. Obesity induced by cafeteria feeding and pregnancy outcome in the rat. Br J Nutr. 2009; 102, 1601–1610.
10.Howie, GJ, Sloboda, DM, Kamal, T, Vickers, MH. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol. 2009; 587, 905–915.
11.Barker, DJ. Fetal growth and adult disease. Br J Obstet Gynaecol. 1992; 99, 275–276.
12.Barker, DJ, Osmond, C, Golding, J, Kuh, D, Wadsworth, ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989; 298, 564–567.
13.de Rooij, SR, Painter, RC, Phillips, DI, et al. Impaired insulin secretion after prenatal exposure to the Dutch famine. Diabetes Care. 2006; 29, 1897–1901.
14.de Rooij, SR, Painter, RC, Roseboom, TJ, et al. Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia. 2006; 49, 637–643.
15.Gagnon, R. Placental insufficiency and its consequences. Eur J Obstet Gynecol Reprod Biol. 2003; 110(Suppl. 1), S99–S107.
16.Jansson, T, Powell, TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond). 2007; 113, 1–13.
17.Seckl, JR, Benediktsson, R, Lindsay, RS, Brown, RW. Placental 11 beta-hydroxysteroid dehydrogenase and the programming of hypertension. J Steroid Biochem Mol Biol. 1995; 55, 447–455.
18.Wyrwoll, CS, Seckl, JR, Holmes, MC. Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology. 2009; 150, 1287–1293.
19.Hewitt, DP, Mark, PJ, Waddell, BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology. 2006; 147, 5568–5574.
20.Wyrwoll, CS, Mark, PJ, Mori, TA, Puddey, IB, Waddell, BJ. Prevention of programmed hyperleptinemia and hypertension by postnatal dietary omega-3 fatty acids. Endocrinology. 2006; 147, 599–606.
21.Smith, JT, Waddell, BJ. Leptin distribution and metabolism in the pregnant rat: transplacental leptin passage increases in late gestation but is reduced by excess glucocorticoids. Endocrinology. 2003; 144, 3024–3030.
22.Le Bacquer, O, Petroulakis, E, Paglialunga, S, et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest. 2007; 117, 387–396.
23.Um, SH, Frigerio, F, Watanabe, M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature. 2004; 431, 200–205.
24.Roos, S, Jansson, N, Palmberg, I, et al. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol. 2007; 582, 449–459.
25.Roos, S, Powell, TL, Jansson, T. Placental mTOR links maternal nutrient availability to fetal growth. Biochem Soc Trans. 2009; 37, 295–298.
26.Sloboda, DM, Howie, GJ, Pleasants, A, Gluckman, PD, Vickers, MH. Pre- and postnatal nutritional histories influence reproductive maturation and ovarian function in the rat. PLoS One. 2009; 4, e6744.
27.Barak, Y, Nelson, MC, Ong, ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999; 4, 585–595.
28.Hewitt, DP, Mark, PJ, Waddell, BJ. Placental expression of peroxisome proliferator-activated receptors in rat pregnancy and the effect of increased glucocorticoid exposure. Biol Reprod. 2006; 74, 23–28.
29.Pathipati, P, Surus, A, Williams, CE, Scheepens, A. Delayed and chronic treatment with growth hormone after endothelin-induced stroke in the adult rat. Behav Brain Res. 2009; 204, 93–101.
30.Lareu, RR, Harve, KS, Raghunath, M. Emulating a crowded intracellular environment in vitro dramatically improves RT-PCR performance. Biochem Biophys Res Commun. 2007; 363, 171–177.
31.Rozen, S, Skaletsky, HJ. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology (eds. Krawetz S, Misener S), 2000; pp. 365–386. Humana Press: Totowa, NJ.
32.Vandesompele, J, De Preter, K, Pattyn, F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3, RESEARCH0034, 1–11.
33.Snedecor, G, Cochrane, W. Statistical Methods 1989. Iowa State University Press: Ames, IA.
34.Coan, PM, Vaughan, OR, Sekita, Y, et al. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J Physiol. 2010; 527–538.
35.Gangloff, YG, Mueller, M, Dann, SG, et al. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol. 2004; 24, 9508–9516.
36.Mparmpakas, D, Zachariades, E, Foster, H, et al. Expression of mTOR and downstream signalling components in the JEG-3 and BeWo human placental choriocarcinoma cell lines. Int J Mol Med. 2010; 25, 65–69.
37.Jansson, N, Pettersson, J, Haafiz, A, et al. Down-regulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol. 2006; 576, 935–946.
38.Xue, Q, Nagy, JA, Manseau, EJ, et al. Rapamycin inhibition of the Akt/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase. Arterioscler Thromb Vasc Biol. 2009; 29, 1172–1178.
39.Wen, HY, Abbasi, S, Kellems, RE, Xia, Y. mTOR: a placental growth signaling sensor. Placenta. 2005; 26(Suppl. A), S63–S69.
40.Xu, Y, Wang, Q, Cook, TJ, Knipp, GT. Effect of placental fatty acid metabolism and regulation by peroxisome proliferator activated receptor on pregnancy and fetal outcomes. J Pharm Sci. 2007; 96, 2582–2606.
41.Capobianco, E, White, V, Higa, R, Martinez, N, Jawerbaum, A. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats. Mol Hum Reprod. 2008; 14, 491–499.
42.Jarvie, E, Hauguel-de-Mouzon, S, Nelson, SM, et al. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (Lond). 2010; 119, 123–129.
43.Robillard, PY, Christon, R. Lipid intake during pregnancy in developing countries: possible effect of essential fatty acid deficiency on fetal growth. Prostaglandins Leukot Essent Fatty Acids. 1993; 48, 139–142.
44.Amico, JA, Thomas, A, Crowley, RS, Burmeister, LA. Concentrations of leptin in the serum of pregnant, lactating, and cycling rats and of leptin messenger ribonucleic acid in rat placental tissue. Life Sci. 1998; 63, 1387–1395.
45.Dessolin, S, Schalling, M, Champigny, O, et al. Leptin gene is expressed in rat brown adipose tissue at birth. FASEB J. 1997; 11, 382–387.
46.Wlodek, ME, Westcott, KT, O'Dowd, R, et al. Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP. Am J Physiol Regul Integr Comp Physiol. 2005; 288, R1620–R1627.
47.Vickers, MH, Breier, BH, Cutfield, WS, Hofman, PL, Gluckman, PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000; 279, E83–E87.
48.Burton, PJ, Waddell, BJ. 11 beta-Hydroxysteroid dehydrogenase in the rat placenta: developmental changes and the effects of altered glucocorticoid exposure. J Endocrinol. 1994; 143, 505–513.
49.Lindsay, RS, Lindsay, RM, Waddell, BJ, Seckl, JR. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia. 1996; 39, 1299–1305.
50.Moritz, KM, Johnson, K, Douglas-Denton, R, Wintour, EM, Dodic, M. Maternal glucocorticoid treatment programs alterations in the renin-angiotensin system of the ovine fetal kidney. Endocrinology. 2002; 143, 4455–4463.
51.Sloboda, DM, Newnham, JP, Challis, JR. Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term. J Endocrinol. 2000; 165, 79–91.
52.Fowden, AL, Ward, JW, Wooding, FP, Forhead, AJ, Constancia, M. Programming placental nutrient transport capacity. J Physiol. 2006; 572, 5–15.
53.Jansson, T, Cetin, I, Powell, TL, et al. Placental transport and metabolism in fetal overgrowth – a workshop report. Placenta. 2006; 27(Suppl. A), S109–S113.
54.Jones, HN, Woollett, LA, Barbour, N, et al. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. FASEB J. 2009; 23, 271–278.
55.Fowden, AL, Sferruzzi-Perri, AN, Coan, PM, Constancia, M, Burton, GJ. Placental efficiency and adaptation: endocrine regulation. J Physiol. 2009; 587, 3459–3472.
56.Fowden, AL, Forhead, AJ. Endocrine mechanisms of intrauterine programming. Reproduction. 2004; 127, 515–526.
57.Mark, PJ, Smith, JT, Waddell, BJ. Placental and fetal growth retardation following partial progesterone withdrawal in rat pregnancy. Placenta. 2006; 27, 208–214.